49MO IMpassion130: Final OS analysis from the pivotal phase III study of atezolizumab + nab-paclitaxel vs placebo + nab-paclitaxel in previously untreated locally advanced or metastatic triple-negative breast cancer
| Autor: | Iwata, H., Emens, L., Adams, S., Barrios, C.H., Diéras, V., Loi, S., Rugo, H.S., Schneeweiss, A., Winer, E.P., Patel, S., Henschel, V., Swat, A., Kaul, M., Molinero, L., Chui, S.S., Schmid, P. |
|---|---|
| Zdroj: | In Annals of Oncology November 2020 31 Supplement 6:S1261-S1262 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|